Novel Technologies News for October 2015

Novel Technologies News Archive

Glimmer of hope for Duchenne muscular dystrophy Glimmer of hope for Duchenne muscular dystrophy

Scientists have found what could one day lead to a promising treatment for those with a crippling disease, Duchenne muscular dystrophy.

New publication highlights A1M protein’s role in regulating free haemoglobin New publication highlights A1M protein’s role in regulating free haemoglobin

Scientists associated with A1M Pharma have published a scientific article that deepens the understanding of how free hemoglobin affects the function of the heart and the possibility to neutralize these effects with A1M, a protein that occurs naturally in the human body. The article was published on September 25 in the scientific journal Free Radical Biology and Medicine.

Cambridge Cognition enters ‘Hot’ Cognition arena Cambridge Cognition enters ‘Hot’ Cognition arena

Cambridge Cognition Holdings plc (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, announces two new licence agreements which extend the Company’s testing capabilities into new areas of research, enabling assessment of 'Hot' cognition – mental processes that are influenced by emotion and social interaction – to be performed reliably and routinely for the first time.